Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

April 14, 2018

Study Completion Date

October 13, 2018

Conditions
Pain, PostoperativeShoulder Joint DisorderAmbulatory Surgical ProceduresBrachial Plexus Block
Interventions
DRUG

Dexamethasone

0.4 millilitres (mL) of 10 milligram per mL sterile, preservative free solution diluted in 50 or 100mL of normal saline and administered once, over approximately 15 minutes, in the immediate preoperative period.

DRUG

Dexmedetomidine

0.5 millilitres (mL) of 100 microgram per mL sterile, preservative free solution diluted in 50 or 100mL of normal saline and administered once, over approximately 15 minutes, in the immediate preoperative period.

Trial Locations (1)

R3M 3E4

Pan Am Surgical Centre, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT03270033 - Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery | Biotech Hunter | Biotech Hunter